Figure 3.
Impact of donor type on disease-free survival, nonrelapse mortality and relapse. Cumulative incidence of DFS (A), NRM (B), and relapse (C) in recipients of MUD HCT or haplo-HCT.

Impact of donor type on disease-free survival, nonrelapse mortality and relapse. Cumulative incidence of DFS (A), NRM (B), and relapse (C) in recipients of MUD HCT or haplo-HCT.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal